Inventor profile of:

Michael Houghton

City:

Edmonton

Country:

Canada

Published Applications:

15

Last publication date:

2024-09-26

Top Assignees for applications by Michael Houghton

The entities that hold a legal rights for patent applications filed by inventor Houghton Michael:

Recent patent applications by Houghton Michael

Michael Houghton from Edmonton, CA has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-09-26
US20240316186A1
Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#2 | 2023-07-27
US20230235290A1
Chemistry; metallurgy

RECOMBINANT CARDIOMYOCYTES AND CARDIOMYOCYTE CELL LINES EXPRESSING HERG

#3 | 2023-03-30
US20230098265A1
Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#4 | 2022-07-21
US20220226335A1
Human necessities

Non-Peptidic Heterocycle-Containing Compounds for the Treatment of Alzheimer?s Disease

#5 | 2021-05-20
US20210145963A9
Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#6 | 2020-06-11
US20200181577A1
Chemistry; metallurgy

Recombinant cardiomyocytes and cardiomyocyte cell lines expressing hERG

#7 | 2018-07-26
US20180209992A1
Physics

Methods and compositions for treatment of autoimmune hepatitis

#8 | 2018-03-08
US20180068053A1
Physics

SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY USING CARDIAC SODIUM ION CHANNEL MODELS

#9 | 2018-01-11
US20180011110A1
Physics

Methods and compositions in diagnosis of chronic fatigue syndrome/myalgic encephalomyelitis

#10 | 2017-06-01
US20170153251A1
Physics

Methods of treatment of primary sclerosing cholangitis

#11 | 2016-03-10
US20160067332A1
Human necessities

E1E2 HCV VACCINES AND METHODS OF USE

#12 | 2015-12-31
US20150376621A1
Chemistry; metallurgy

MODIFIED SMALL INTERFERING RNA MOLECULES AND METHODS OF USE

#13 | 2015-10-29
US20150307590A1
Chemistry; metallurgy

Immunomodulatory peptides and methods of use thereof

#14 | 2015-08-06
US20150219664A1
Physics

Methods and compositions for diagnosis of inflammatory liver disease

#15 | 2015-07-09
US20150193575A1
Physics

SYSTEMS AND METHODS OF SELECTING COMPOUNDS WITH REDUCED RISK OF CARDIOTOXICITY

InventorID:

1222115 ⎘